Health Canada announced new mitigation measures today on the neonicotinoids clothianidin and thiamethoxam, pesticides which are sold as seed treatment or sprays to protect agricultural crops from various insects.
“Scientific evidence shows that with the proposed restrictions applied, the use of clothianidin and thiamethoxam does not present an unacceptable risk to bees,” said Margherita Conti, an official with Health Canada’s pest management regulatory agency.
The PMRA is updating the pollinator risk assessment for imidacloprid based on additional data from the registrant, additional literature that has recently been published, and the comments that were received during the public consultation period for the preliminary assessment (REV2016-05, Re-evaluation of Imidacloprid – Preliminary Pollinator Assessment). The PMRA expects to publish a proposed decision regarding imidacloprid pollinator safety in March 2018.
Read more on the proposed clothianidin and thiamethoxam re-evaluation decisions:
- PRVD2017-23: Proposed Re-evaluation Decision on Clothianidin and Its Associated End-use Products: Pollinator Re-evaluation
- PRVD2017-24: Proposed Re-evaluation Decision on Thiamethoxam and Its Associated End-use Products: Pollinator Re-evaluation